JP2013515698A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515698A5
JP2013515698A5 JP2012545331A JP2012545331A JP2013515698A5 JP 2013515698 A5 JP2013515698 A5 JP 2013515698A5 JP 2012545331 A JP2012545331 A JP 2012545331A JP 2012545331 A JP2012545331 A JP 2012545331A JP 2013515698 A5 JP2013515698 A5 JP 2013515698A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
group
methyl
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012545331A
Other languages
English (en)
Japanese (ja)
Other versions
JP5781537B2 (ja
JP2013515698A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/070562 external-priority patent/WO2011076878A1/en
Publication of JP2013515698A publication Critical patent/JP2013515698A/ja
Publication of JP2013515698A5 publication Critical patent/JP2013515698A5/ja
Application granted granted Critical
Publication of JP5781537B2 publication Critical patent/JP5781537B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012545331A 2009-12-23 2010-12-22 ヒスタミンh4受容体アンタゴニストとしてのアミノアルキルピリミジン誘導体 Expired - Fee Related JP5781537B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09382302 2009-12-23
EP09382302.9 2009-12-23
US30757910P 2010-02-24 2010-02-24
US61/307,579 2010-02-24
PCT/EP2010/070562 WO2011076878A1 (en) 2009-12-23 2010-12-22 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2013515698A JP2013515698A (ja) 2013-05-09
JP2013515698A5 true JP2013515698A5 (https=) 2014-02-20
JP5781537B2 JP5781537B2 (ja) 2015-09-24

Family

ID=41667549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012545331A Expired - Fee Related JP5781537B2 (ja) 2009-12-23 2010-12-22 ヒスタミンh4受容体アンタゴニストとしてのアミノアルキルピリミジン誘導体

Country Status (17)

Country Link
US (1) US8901146B2 (https=)
EP (1) EP2516420B8 (https=)
JP (1) JP5781537B2 (https=)
KR (1) KR101740085B1 (https=)
CN (1) CN102803248B (https=)
AR (1) AR079725A1 (https=)
AU (1) AU2010334804B2 (https=)
BR (1) BR112012017126A2 (https=)
CA (1) CA2785353C (https=)
IL (1) IL220554A (https=)
MX (1) MX345142B (https=)
NZ (1) NZ601021A (https=)
PE (1) PE20121505A1 (https=)
RU (1) RU2573828C2 (https=)
TW (1) TWI487697B (https=)
UA (1) UA107818C2 (https=)
WO (1) WO2011076878A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2629006T3 (es) 2009-10-29 2017-08-07 Vectura Limited Derivados que contienen N-heteroarilo como inhibidores de la quinasa jak3
PT3513793T (pt) * 2011-09-02 2021-05-10 Incyte Holdings Corp Heterociclilaminas como inibidores de pi3k
US11180480B2 (en) 2017-10-17 2021-11-23 Sensorion Synthesis of 4-aminopyrimidine compounds
GB201817047D0 (en) 2018-10-19 2018-12-05 Heptares Therapeutics Ltd H4 antagonist compounds
JP2022165429A (ja) * 2019-10-02 2022-11-01 Meiji Seikaファルマ株式会社 ヒスタミンh4受容体調節作用を有する新規トリアジン誘導体
CN117018194B (zh) * 2023-07-26 2026-04-17 同济大学 毒蕈碱型受体5型受体拮抗剂的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135714A0 (en) * 1997-11-04 2001-05-20 Pfizer Prod Inc Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
ES2273047T3 (es) * 2002-10-28 2007-05-01 Bayer Healthcare Ag Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa.
JP4544999B2 (ja) * 2002-11-25 2010-09-15 持田製薬株式会社 4−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
EP1505064A1 (en) * 2003-08-05 2005-02-09 Bayer HealthCare AG 2-Aminopyrimidine derivatives
WO2005054239A1 (en) 2003-12-05 2005-06-16 Bayer Healthcare Ag 2-aminopyrimidine derivatives
WO2006110763A1 (en) * 2005-04-08 2006-10-19 Bayer Pharmaceuticals Corporation Pyrimidine derivatives and their use for the treatment of cancer
CA2622372A1 (en) 2005-09-13 2007-03-22 Palau Pharma, S.A. 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity
JP5191391B2 (ja) * 2005-11-01 2013-05-08 ターゲジェン インコーポレーティッド キナーゼのビ−アリールメタ−ピリミジン阻害剤
NL2000323C2 (nl) 2005-12-20 2007-11-20 Pfizer Ltd Pyrimidine-derivaten.
US20100035863A1 (en) 2006-09-12 2010-02-11 Ucb Pharma, S.A. 2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions
US7985745B2 (en) 2006-10-02 2011-07-26 Abbott Laboratories Method for pain treatment
CL2008000467A1 (es) 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
WO2009068512A1 (en) * 2007-11-30 2009-06-04 Palau Pharma, S. A. 2 -amino-pyrimidine derivatives as histamine h4 antagonists
PE20091524A1 (es) 2007-12-19 2009-09-25 Palau Pharma Sa Derivados de 2-aminopirimidina
CN101903385B (zh) * 2007-12-21 2013-11-06 帕劳制药股份有限公司 作为组胺h4受体拮抗剂的4-氨基嘧啶衍生物

Similar Documents

Publication Publication Date Title
JP2013515698A5 (https=)
JP2017533968A5 (https=)
JP2015514060A5 (https=)
JP2013542261A5 (https=)
JP2016540742A5 (https=)
JP2013537203A5 (https=)
JP2017514910A5 (https=)
JP2020502092A5 (https=)
JP2018502912A5 (https=)
JP2016514159A5 (https=)
JP2011132222A5 (https=)
JP2016540749A5 (https=)
JP2014510727A5 (https=)
JP2013502430A5 (https=)
JP2016525102A5 (https=)
JP2014520898A5 (https=)
JP2013063968A5 (https=)
JP2015508092A5 (https=)
JP2015509534A5 (https=)
JP2016525136A5 (https=)
JP2019505529A5 (https=)
JP2015522589A5 (https=)
JP2017517512A5 (https=)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
RU2016137668A (ru) Новые производные каннабидиол-хинона